Efficacy and safety of retreatment with nivolumab in metastatic melanoma patients previously treated with nivolumab

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, October 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy: 1 policy source
twitter: 5 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 53 Dimensions

Readers on

mendeley: 29 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Dosing and Timing of Immuno-Oncology Drugs

Cited by Canadian Agency for Drugs and Technologies in Health on 21 Nov 2019

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.